Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  SOPHiA GENETICS, Inc.

Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

Read more ››
By: GlobeNewswire - 30 Apr 2024

Appendix 4C – Q3 FY24 Quarterly Cash Flow Report

Read more ››
By: GlobeNewswire - 30 Apr 2024

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  InflaRx N.V.

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Tenax Therapeutics Inc.

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Daré Bioscience, Inc.

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  XOMA Corporation

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Invivyd, Inc.

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  BioRestorative Therapies, Inc.

Mobile-health Network Solutions Opens New Retail Pharmacy

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Mobile-health Network Solutions (MNDR)

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Orchestra BioMed, Inc.

Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Ultragenyx Pharmaceutical Inc.

Shape Therapeutics to Showcase RNA Editing in the Brain and Validation of their Stable AAV Producer Cell Line at ASGCT 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Biora Therapeutics, Inc.

In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Matinas BioPharma Holdings Inc.

Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Alimera Sciences, Inc.

INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  INmune Bio Inc.

Reflect Scientific Inc Secures $550,000 Sale with Major BioPharma Company

Read more ››
By: GlobeNewswire - 30 Apr 2024

Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Panbela Therapeutics, Inc.

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Akero Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑